Geras-US

Longitudinal Cohort Study of Resource Use and Cost of Mild Cognitive Impairment and Mild Dementia Due to Alzheimer's Disease in the United States (GERAS-US)

Geras-US [NCT02951598]

Description: The purpose of this study is to learn about health care use, costs, and clinical outcomes over time for amyloid positive participants with early stages of AD in the United States. This study is for research purposes only, and is not intended to treat any medical condition. No study therapy(ies) for AD will be administered.

Primary Investigator: Keyes

Drug/Device Information
The goal is to gain an understanding of the cost of care, a description of care, and clinical outcomes over time for stages of AD that are understudied in real world US settings
Prospective, longitudinal cohort study of patients with MCI due to AD and mild AD dementia
Eli Lilly and Company